Postes actifs de Nicholas Mark Barnes
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Celentyx Ltd.
 Celentyx Ltd. BiotechnologyHealth Technology Celentyx Ltd. provides research and development on human immune disease. The firm's services include rapid analysis screening of drug action on physiological and pathological human immune tissues and cells. It provides services by disease, cell type, assay through its ImmuKnowlogy platform technology. The company was founded by Nicholas Mark Barnes and John Gordon in 2004 and is headquartered in Birmingham, the United Kingdom. | Directeur/Membre du Conseil | 01/01/2004 | - |
| Directeur Général | 01/01/2004 | - | |
| Fondateur | 01/01/2004 | - | |
| University of Birmingham | Corporate Officer/Principal | - | - |
| The International Union of Basic & Clinical Pharmacology | Corporate Officer/Principal | 04/04/2014 | - |
Historique de carrière de Nicholas Mark Barnes
Statistiques
Internationale
| Royaume-Uni | 3 |
| Etats-Unis | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectorielle
| Consumer Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Celentyx Ltd.
Celentyx Ltd. BiotechnologyHealth Technology Celentyx Ltd. provides research and development on human immune disease. The firm's services include rapid analysis screening of drug action on physiological and pathological human immune tissues and cells. It provides services by disease, cell type, assay through its ImmuKnowlogy platform technology. The company was founded by Nicholas Mark Barnes and John Gordon in 2004 and is headquartered in Birmingham, the United Kingdom. | Health Technology |
| The International Union of Basic & Clinical Pharmacology |
- Bourse
- Insiders
- Nicholas Mark Barnes
- Expérience
